J. H. Cho and P. K. Gregersen, Genomics and the multifactorial nature of human autoimmune disease, N Engl J Med, vol.365, issue.17, pp.1612-1623, 2011.

Y. R. Li, S. D. Zhao, and J. Li, Genetic sharing and heritability of paediatric age of onset autoimmune diseases, Nat Commun, vol.6, issue.1, p.8442, 2015.

A. Fischer, J. Provot, J. Jais, and A. Alcais, Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies, J Allergy Clin Immunol, vol.140, issue.5, pp.1388-1393, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01783653

F. Rieux-laucat, L. Deist, F. Hivroz, and C. , Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity, Science, vol.268, issue.5215, pp.1347-1349, 1995.

B. E. Oftedal, A. Hellesen, and M. M. Erichsen, Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases, Immunity, vol.42, issue.6, pp.1185-1196, 2015.

C. L. Bennett, J. Christie, and F. Ramsdell, The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3, Nat Genet, vol.27, issue.1, pp.20-21, 2001.

A. Fischer and A. Rausell, What do primary immunodeficiencies tell us about the essentiality/redundancy of immune responses?, Semin Immunol, vol.36, pp.13-16, 2018.

S. Sakaguchi, F. Powrie, and R. M. Ransohoff, Reestablishing immunological self-tolerance in autoimmune disease, Nat Med, vol.18, issue.4, p.630, 2012.

, Nat Med, vol.18, issue.1, pp.54-58, 2012.

Y. Feng, A. Arvey, T. Chinen, J. Van-der-veeken, G. Gasteiger et al., Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus, Cell, vol.158, issue.4, pp.749-763, 2014.

K. Wing and S. Sakaguchi, Regulatory T cells exert checks and balances on self tolerance and autoimmunity, Nat Immunol, vol.11, issue.1, pp.7-13, 2010.

F. Melchers, Checkpoints that control B cell development, J Clin Invest, vol.125, issue.6, pp.2203-2210, 2015.

R. S. Evans, K. Takahashi, R. T. Duane, R. Payne, and C. Liu, Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology, AMA Arch Intern Med, vol.87, issue.1, pp.48-65, 1951.

S. Sava?an, I. Warrier, and Y. Ravindranath, The spectrum of Evans' syndrome, Arch Dis Child, vol.77, issue.3, pp.245-248, 1997.

C. Besnard, E. Levy, and N. Aladjidi, Members of the French Reference Center for Pediatric Autoimmune Cytopenias (CEREVANCE)

, Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations, Clin Immunol, vol.188, pp.52-57, 2018.

S. A. Miller, D. D. Dykes, and H. F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res, vol.16, issue.3, p.1215, 1988.

D. Schubert, C. Bode, and R. Kenefeck, Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations, Nat Med, vol.20, issue.12, pp.1410-1416, 2014.

I. Angulo, O. Vadas, and F. Garçon, Phosphoinositide 3-kinase d gene mutation predisposes to respiratory infection and airway damage, Science, vol.342, issue.6160, pp.866-871, 2013.

C. Schwab, A. Gabrysch, and P. Olbrich, Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects, J Allergy Clin Immunol, vol.142, issue.6, pp.1932-1946, 2018.

H. S. Kuehn, I. Caminha, and J. E. Niemela, FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome, J Immunol, vol.186, issue.10, pp.6035-6043, 2011.

B. Lo, K. Zhang, and W. Lu, Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy, Science, vol.349, issue.6246, pp.436-440, 2015.

T. P. Vogel, J. D. Milner, and M. A. Cooper, The ying and yang of STAT3 in human disease, J Clin Immunol, vol.35, issue.7, pp.615-623, 2015.

M. A. Weinreich, T. P. Vogel, V. K. Rao, and J. D. Milner, Up, down, and all around: diagnosis and treatment of novel STAT3 variant, Front Pediatr, vol.5, p.49, 2017.

. Artemis-deficient and . Scid, Blood, vol.123, issue.2, pp.281-289, 2014.

J. D. Milner, T. P. Vogel, and L. Forbes, Earlyonset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations, Blood, vol.125, issue.4, pp.591-599, 2015.

H. S. Kuehn, B. Boisson, and C. Cunningham-rundles, Loss of B cells in patients with heterozygous mutations in IKAROS, N Engl J Med, vol.374, issue.11, pp.1032-1043, 2016.

D. Boutboul, H. S. Kuehn, and Z. Van-de-wyngaert, Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency, J Clin Invest, vol.128, issue.7, pp.3071-3087, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02343581

D. Boutboul, A. Hoshino, and H. Kuehn, Heterozygous germline IKZF1 gain-offunction mutation causes chilldhood-onset polyautoimmunity and lymphoproliferation, Proceedings from the 18th biennial European Society for Immunodeficiencies, pp.24-27, 2018.

S. E. Turvey, A. Durandy, and A. Fischer, The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency, J Allergy Clin Immunol, vol.134, issue.2, pp.276-284, 2014.

A. L. Snow, W. Xiao, and J. R. Stinson, Congenital B cell lymphocytosis explained by novel germline CARD11 mutations, J Exp Med, vol.209, issue.12, pp.2247-2261, 2012.

H. Dadi, T. A. Jones, and D. Merico, Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11), J Allergy Clin Immunol, vol.141, issue.5, pp.1818-1830, 2018.

C. A. Ma, J. R. Stinson, and Y. Zhang, Germline hypomorphic CARD11 mutations in severe atopic disease, Nat Genet, vol.49, issue.11, p.1661, 2017.

, Nat Genet, vol.49, issue.8, pp.1192-1201, 2017.

B. Dorjbal, J. R. Stinson, and C. A. Ma, Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease, J Allergy Clin Immunol, vol.143, issue.4, pp.1482-1495, 2019.

M. J. Ombrello, E. F. Remmers, and G. Sun, Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions, N Engl J Med, vol.366, issue.4, pp.330-338, 2012.

Q. Zhou, G. Lee, and J. Brady, A hypermorphic missense mutation in PLCG2, encoding phospholipase Cg2, causes a dominantly inherited autoinflammatory disease with immunodeficiency, Am J Hum Genet, vol.91, issue.4, pp.713-720, 2012.

J. F. Neves, R. Doffinger, and G. Barcena-morales, Novel PLCG2 mutation in a patient with APLAID and cutis laxa, Front Immunol, vol.9, p.2863, 2018.

D. Bel, K. L. Ragotte, R. J. Saferali, and A. , JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome, J Allergy Clin Immunol, vol.139, issue.6, pp.2016-2020, 2017.

L. Moens, G. Bucciol, and N. Hernandez, Human IFNAR1 deficiency causes an inborn error of immunity with increased susceptibility to viral infections, Proceedings from the 18th biennial European Society for Immunodeficiencies, vol.24, 2018.

A. De-rocca-serra-nédélec, E. T. Tréguer, and K. , Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature, Proc Natl Acad Sci, vol.109, issue.11, pp.4257-4262, 2012.

N. Lanzarotti, J. Bruneau, and A. Trinquand, RAS-associated lymphoproliferative disease evolves into severe juvenile myelo-monocytic leukemia, Blood, vol.123, issue.12, pp.1960-1963, 2014.

B. L. Loeys, J. Chen, and E. R. Neptune, A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2, Nat Genet, vol.37, issue.3, pp.275-281, 2005.

N. Aladjidi, H. Fernandes, and T. Leblanc, Evans syndrome in children: long-term outcome in a prospective French national observational cohort, Front Pediatr, vol.3, p.79, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02413085

I. J. Nijman, J. M. Van-montfrans, and M. Hoogstraat, Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies, J Allergy Clin Immunol, vol.133, issue.2, pp.529-534, 2014.

N. Aladjidi, G. Leverger, and T. Leblanc, New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children, Haematologica, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01120646

G. Moulis, A. Palmaro, J. Montastruc, B. Godeau, M. Lapeyre-mestre et al., Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France, Blood, vol.124, issue.22, pp.3308-3315, 2014.

M. Michel, V. Chanet, and A. Dechartres, The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases, Blood, vol.114, issue.15, pp.3167-3172, 2009.

D. T. Teachey, C. S. Manno, and K. M. Axsom, Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS), Blood, vol.105, issue.6, pp.2443-2448, 2005.

S. E. Flanagan, E. Haapaniemi, and M. A. Russell, Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease, Nat Genet, vol.46, issue.8, pp.812-814, 2014.

C. Schuetz, K. Huck, and S. Gudowius, An immunodeficiency disease with RAG mutations and granulomas, N Engl J Med, vol.358, pp.2030-2038, 2008.

M. Takagi, K. Shinoda, and J. Piao, Autoimmune lymphoproliferative syndromelike disease with somatic KRAS mutation, Blood, vol.117, issue.10, pp.2887-2890, 2011.

M. L. Loh, D. S. Sakai, and C. Flotho, Mutations in CBL occur frequently in juvenile myelomonocytic leukemia, Blood, vol.114, issue.9, pp.1859-1863, 2009.

B. Neven, A. Magerus-chatinet, and B. Florkin, A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation, Blood, vol.118, issue.18, pp.4798-4807, 2011.

T. I. Coulter, A. Chandra, and C. M. Bacon, Clinical spectrum and features of activated phosphoinositide 3-kinase d syndrome: a large patient cohort study, J Allergy Clin Immunol, vol.139, issue.2, pp.597-606, 2017.

D. Eletto, S. O. Burns, and I. Angulo, Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection, Nat Commun, vol.7, p.13992, 2016.

V. K. Rao, S. Price, and K. Perkins, Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS). Pediatr Blood Cancer, 2009.

P. A. Frischmeyer-guerrerio, A. L. Guerrerio, and G. Oswald, TGFb receptor mutations impose a strong predisposition for human allergic disease, Sci Transl Med, vol.5, pp.195-94, 0195.

R. Bottema, M. Kerkhof, and N. E. Reijmerink, Gene-gene interaction in regulatory T-cell function in atopy and asthma development in childhood, J Allergy Clin Immunol, vol.126, issue.2, pp.1-10, 2010.

H. Takatori, H. Kawashima, and A. Matsuki, Helios enhances Treg cell function in cooperation with FoxP3, Arthritis Rheumatol, vol.67, issue.6, pp.1491-1502, 2015.

L. Zheng, G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch et al., Induction of apoptosis in mature T cells by tumour necrosis factor, Nature, vol.377, issue.6547, pp.348-351, 1995.

R. Pérez-de-diego, V. Sancho-shimizu, and L. Lorenzo, Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis, Immunity, vol.33, issue.3, pp.400-411, 2010.

U. Rozovski, J. Y. Wu, and D. M. Harris, Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells, Blood, vol.123, issue.24, pp.3797-3802, 2014.

M. Hikida, S. Casola, and N. Takahashi, PLC-gamma2 is essential for formation and maintenance of memory B cells, J Exp Med, vol.206, issue.3, pp.681-689, 2009.

P. Uhlén, P. M. Burch, C. I. Zito, M. Estrada, B. E. Ehrlich et al., Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling, Proc Natl Acad Sci, vol.103, issue.7, pp.2160-2165, 2006.

S. Klein-hessling, K. Muhammad, and M. Klein, NFATc1 controls the cytotoxicity of CD8+ T cells, Nat Commun, vol.8, issue.1, p.511, 2017.

S. Bhattacharyya, J. Deb, and A. K. Patra, NFATc1 affects mouse splenic B cell function by controlling the calcineurin--NFAT signaling network, J Exp Med, vol.208, issue.4, pp.823-839, 2011.

W. Zhang, S. P. Neo, and J. Gunaratne, Feedback regulation on PTEN/AKT pathway by the ER stress kinase PERK mediated by interaction with the Vault complex, Cell Signal, vol.27, issue.3, pp.436-442, 2015.

A. Hoshino, S. Okada, and K. Yoshida, Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations, J Allergy Clin Immunol, vol.140, issue.1, pp.223-231, 2017.

A. Krieg, R. G. Correa, and J. B. Garrison, XIAP mediates NOD signaling via interaction with RIP2, Proc Natl Acad Sci USA, vol.106, issue.34, pp.14524-14529, 2009.

F. Cecconi, G. Alvarez-bolado, B. I. Meyer, K. A. Roth, and P. Gruss, Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development, Cell, vol.94, issue.6, pp.727-737, 1998.

S. Chun, A. Casparino, and N. A. Patsopoulos, Limited statistical evidence for shared genetic effects of eQTLs and autoimmune-diseaseassociated loci in three major immune-cell types, Nat Genet, vol.49, issue.4, pp.600-605, 2017.

A. Magerus-chatinet, B. Neven, and M. Stolzenberg, Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation, J Clin Invest, vol.121, issue.1, pp.106-112, 2011.

C. Klemann, M. Esquivel, and A. Magerus-chatinet, Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome, Haematologica, vol.102, issue.2, pp.52-56, 2017.

V. K. Rao, S. Webster, and V. Dalm, activated PI3Kd syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib, Blood, vol.130, issue.21, pp.2307-2316, 2017.

P. Page, M. Bertrand, Y. Fernandes, and H. , Treatment with cyclosporin in auto-immune cytopenias in children: the experience from the French cohort OBS'CEREVANCE, Am J Hematol, 2018.

D. L. Burnett, D. B. Langley, and P. Schofield, Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination, Science, vol.360, issue.6385, pp.223-226, 2018.

L. A. Miosge and C. C. Goodnow, Genes, pathways and checkpoints in lymphocyte development and homeostasis, Immunol Cell Biol, 2005.

, , 2019.

A. Bénédicte-neven, F. Fischer, and . Rieux-laucat,

E. Jeziorski, F. Millot, N. Garcelon, S. Ducassou, Y. Perel et al., Elodie Colomb Bottollier, Fanny Fouyssac, Rosain, Cécile Fourrage, Sylvain Hanein, Mohammed Zarhrate, Marlène Pasquet, Wadih Abou Fabienne Mazerolles

J. Hadjadj, N. Aladjidi, H. Fernandes, and G. Leverger,